慢性支气管炎
基于干细胞的颈椎间盘修复方法的临床成功
基于干细胞的颈椎间盘修复方法已显示出有希望的临床成功. 研究表明疼痛和功能显着改善, 减少重复手术的需要. 干细胞的再生潜力为当前治疗方案的局限性提供了潜在的解决方案, 为改善患者治疗效果和降低医疗成本带来希望.
抗衰老疗法
Mechanism of Intravenous Stem Cell Administration and Its Impact on the Brain for ADHD Treatment
by Dr. Eugene Zadorin, PhD Mechanism of Intravenous Stem Cell Administration and Its Impact on the Brain for ADHD Treatment Stem cell therapy has gained attention as a promising treatment for various neurological conditions, including attention-deficit/hyperactivity disorder (多动症). The intravenous (IV) administration of stem cells, particularly in large doses, offers 阅读更多
慢性支气管炎
基因编辑干细胞在心肌病和心力衰竭治疗中的应用
基因编辑技术, 尤其是 CRISPR-Cas9, 为纠正心肌细胞的遗传缺陷提供了前所未有的机会, 可能彻底改变心肌病和心力衰竭治疗. 本文探讨了基因编辑干细胞的最先进应用, 强调其治疗潜力和临床转化中的挑战.
慢性支气管炎
利用心脏干细胞修复心肌
心脏干细胞具有再生受损心肌的巨大潜力, 提供了一个有前途的治疗途径. 本文深入探讨了利用这些细胞进行有效心脏修复的最新进展, 分析其再生能力并探索创新策略以优化其治疗效果.
慢性支气管炎
恢复心脏收缩力的干细胞策略
**恢复心脏收缩力的干细胞策略**
基于干细胞的疗法为收缩性受损患者恢复心脏功能提供了有希望的途径. 本文分析最新研究进展, 探索干细胞再生受损心脏组织和提高心输出量的潜力.
慢性支气管炎
干细胞在心肌纤维修复和再生中的作用
**干细胞在心脏修复中的作用: 综合分析**
干细胞对于修复和再生心肌具有巨大的希望. 本文探讨了其中的机制, 挑战, 以及干细胞疗法治疗心脏病的潜力, 全面分析它们在恢复心脏功能方面的作用.
慢性支气管炎
内皮干细胞在心脏健康中的作用
**摘抄:**
内皮干细胞 (ESC) 对维持心血管健康起着至关重要的作用. 它们再生受损内皮的能力有助于血管修复, 血管生成, 以及心血管疾病的预防. 了解控制 ESC 功能的机制对于制定旨在促进心脏健康的治疗策略至关重要.
干细胞疗法
High-dose treatment with mesenchymal stem cells enhances hepatocyte metabolic recovery
High-dose mesenchymal stem cell (MSC) therapy significantly boosts hepatocyte metabolic recovery. This analytical study reveals enhanced efficacy compared to lower doses, offering promising new avenues for liver disease treatment. [内容] explores the mechanisms and clinical implications.
干细胞疗法
Efficacy and safety of treatment with mesenchymal stem cells in decompensated liver cirrhosis
间充质干细胞 (MSC) therapy shows promise in treating decompensated liver cirrhosis. This analysis explores the efficacy and safety data from clinical studies, evaluating MSCs’ potential to improve liver function and patient outcomes while assessing associated risks. #livercirrhosis #MSCtherapy #regenerativemedicine
干细胞疗法
Biomarker-guided monitoring of treatment with mesenchymal stem cells in liver disease
Analyze the efficacy of mesenchymal stem cell (MSC) therapy in liver disease via biomarker-guided monitoring. This article explores novel biomarkers to track treatment response, improving patient stratification and optimizing therapeutic outcomes. Learn about the latest advancements in MSC therapy for liver disease.
干细胞疗法
High-dose treatment with mesenchymal stem cells accelerates matrix degradation in cirrhosis
High-dose mesenchymal stem cell (MSC) therapy’s impact on liver cirrhosis is analyzed. Findings reveal accelerated matrix degradation, suggesting potential benefits and risks. Explore the study’s implications for future cirrhosis treatments. #cirrhosis #MSC #stemcelltherapy #liverdisease
干细胞疗法
Treatment with mesenchymal stem cells reverses ductular reaction in cirrhotic liver
间充质干细胞 (MSC) therapy shows promise in reversing ductular reaction (DR) in cirrhosis. Research reveals MSC treatment significantly reduces DR severity, offering a potential novel therapeutic approach for liver disease progression. Learn more about this groundbreaking study.
干细胞疗法
Treatment with mesenchymal stem cells reverses fibrotic signaling via exosomal mRNA cargo
间充质干细胞 (MSC) therapy shows promise in reversing fibrosis. New research reveals MSC-derived exosomes deliver mRNA cargo, actively suppressing fibrotic signaling pathways. This mechanism offers a novel therapeutic target for fibrotic diseases. 了解更多.
临床研究
CRA certification
A Clinical Research Associate (CRA) is a profession defined by Good clinical practice guidelines (ICH GCP). The main function of a clinical research associate is to monitor clinical trials. He or she may work directly with the sponsor company of a clinical trial, as an independent freelancer or for a Contract Research Organization (CRO). 一个 阅读更多
neurology conferences
Current aspects of practical neurology medical conference
Current aspects of practical neurology. Topics: – Cerebrovascular diseases – Epilepsy – Pain syndromes – 帕金森病 – 7 unique meeting formats – 11 hours of training from leading experts – Innovative technologies for clinical analytical – Training in the selection of unbiased medical information for clinical practice – 阅读更多
干细胞疗法
Evidence-based internal medicine: diagnosis and standards.Internal Medicine
Evidence-based internal medicine: diagnosis and standards Internal Medicine 21 九月, Vinnitsa Registration
干细胞疗法
Current issues of medical rehabilitation, balneology and physiotherapy in the sanatorium treatment of adults and children
Current issues of medical rehabilitation, balneology and physiotherapy in the sanatorium treatment of adults and children 28-29 九月, AR Crimea, Evpatoria Registration
干细胞疗法
骨科和创伤学的现代研究
Modern research in orthopedics and Traumatology October 6-7, 2018 Kiev Registration
2018 麻醉学会议
Current issues of diagnosis and treatment of aneurysms of the aorta and heart 2018, 医学会议
Current issues of diagnosis and treatment of aneurysms of the aorta and heart October 20-21, 2018 基辅注册
干细胞治疗
Stem Cell Therapy of Epilepsy .
Stem Cell Therapy of Epilepsy . Epilepsy as one of the most common neurological disorders affects more than 50 million people worldwide with a higher prevalence rate in low-income countries. Excessive electrical discharges in neurons following neural cell damage or loss cause recurrent seizures. One of the most common and 阅读更多
干细胞疗法
Stem cell therapy shows efficacy at treating COVID-19, finds study
Stem cell therapy shows efficacy at treating COVID-19, finds study Researchers in China administered COVID-19 patients with a mesenchymal stem cell therapy that demonstrated success at treating the condition. Blue stem cells A group of researchers has used a stem cell treatment on a patient in Beijing, China to effectively 阅读更多
欧洲的干细胞
间充质干细胞: Therapeutic Potential and Applications
间充质干细胞 (间充质干细胞) hold immense therapeutic potential due to their self-renewal capacity, multipotent differentiation, and paracrine effects. Their applications span regenerative medicine, 组织工程, and immune modulation, offering promising avenues for treating various diseases and injuries.
欧洲的干细胞
Stem Cells in Neurodegenerative Diseases: Potential for Treating ALS and Parkinson’s
Stem cells hold immense potential in revolutionizing the treatment of neurodegenerative diseases like ALS and Parkinson’s. By harnessing their ability to differentiate into neural cells and secrete neurotrophic factors, stem cells offer a promising avenue for neuroprotection, 再生, 和功能恢复.
欧洲的干细胞
Autologous vs. Allogeneic Stem Cell Transplants: Comparative Outcomes
Autologous and allogeneic stem cell transplants offer distinct advantages and challenges in treating various medical conditions. This analytical article compares their outcomes, addressing patient selection criteria, transplant-related complications, and long-term survival rates. Understanding these differences is crucial for healthcare professionals and patients considering stem cell transplantation.
欧洲的干细胞
iPSCs in Neurodegenerative Disease Models: Progress and Limitations
iPSCs offer unprecedented opportunities for modeling neurodegenerative diseases, providing insights into disease mechanisms and potential therapeutic targets. 然而, limitations such as genetic variability, disease heterogeneity, and scalability hinder their full potential.
慢性支气管炎
分离和扩增干细胞群的新方法
**干细胞分离和扩增: 新颖的策略**
分离和扩大干细胞群的新兴方法正在彻底改变再生医学. 本文探讨了提高干细胞纯度的创新技术, 屈服, 和功能, 为组织修复的进步铺平道路, 疾病建模, 和个性化治疗.
慢性支气管炎
克服干细胞移植中的免疫障碍
**克服干细胞移植中的免疫障碍**
免疫屏障给干细胞移植带来重大挑战. 了解这些障碍背后的机制对于制定有效的策略来预防移植排斥和改善移植结果至关重要. 本文分析了克服免疫障碍的最新进展, 包括免疫抑制疗法, 基因编辑, 和免疫耐受诱导.
慢性支气管炎
日本干细胞治疗的进展: 聚焦 iPS 细胞
日本在干细胞治疗方面的进展, 特别是 iPS 细胞, 彻底改变了再生医学领域. 本文深入探讨了科学突破, 临床应用, 以及围绕 iPS 细胞的伦理考虑, 深入了解其变革潜力和干细胞研究的未来.
慢性支气管炎
南非的干细胞研究: 用再生医学解决健康差异
南非的干细胞研究工作有望彻底改变医疗保健, 特别是在解决健康差距方面. 通过利用再生医学的潜力, 研究人员旨在解决流行病并改善获得先进治疗的机会, 促进更公平的医疗保健体系.